Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.86 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.61 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.54 |
| ▸ | MMP3 | P08254 | 1/20 | 0.52 |
| ▸ | KIF11 | P52732 | 2/20 | 0.52 |
| ▸ | HRH3 | Q9Y5N1 | 5/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | MMP12 | P39900 | 1/20 | 0.44 |
| ▸ | MMP13 | P45452 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4651866 | 1.00 | CYP2A6 (0.86) | CYP2A6TSHRHSD17B10LOXL2MMP3 | |
| Cyclohexane SCHEMBL27471978 | 0.94 | CYP2A6 (0.76) | CYP2A6TSHRHSD17B10LOXL2MMP3 | |
| SCHEMBL91062 | 0.93 | CYP2A6 (1.00) | CYP2A6TSHRHSD17B10LOXL2CYP19A1 | |
| SCHEMBL25188141 | 0.90 | CYP2A6 (0.70) | CYP2A6TSHRHSD17B10LOXL2MMP3 | |
| SCHEMBL14228591 | 0.89 | CYP2A6 (0.68) | CYP2A6TSHRHSD17B10HRH3 | |
| SCHEMBL7666462 | 0.86 | CYP2A6 (0.86) | CYP2A6TSHRHSD17B10LOXL2CYP19A1 | |
| SCHEMBL19743177 | 0.85 | CYP2A6 (0.63) | CYP2A6TSHRHSD17B10LOXL2KIF11 | |
| SCHEMBL10660521 | 0.84 | CYP2A6 (0.61) | CYP2A6TSHRHSD17B10LOXL2KIF11 | |
| SCHEMBL11457698 | 0.84 | CYP2A6 (0.61) | CYP2A6TSHRHSD17B10LOXL2KIF11 | |
| SCHEMBL14228600 | 0.83 | CYP2A6 (0.60) | CYP2A6TSHRHSD17B10HRH3CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250011590-A1 | OPTICAL FILM AND POLARIZING PLATE | TOSOH CORPORATION (JP) | 2025-01-09 | — | — | US | disclosed |
| EP-4431989-A1 | OPTICAL FILM AND POLARIZING PLATE | Tosoh Corporation (JP) | 2024-09-18 | — | — | EP | disclosed |
| US-20240239934-A1 | FUMARIC ACID DIESTER RESIN, FILM AND POLARIZING PLATE | TOSOH CORPORATION (JP) | 2024-07-18 | — | — | US | disclosed |
| EP-4299283-A1 | FUMARIC ACID DIESTER RESIN, FILM AND POLARIZING PLATE | Tosoh Corporation (JP) | 2024-01-03 | — | — | EP | disclosed |
| WO-2023090353-A1 | OPTICAL FILM AND POLARIZING PLATE | 東ソー株式会社 | 2023-05-25 | — | — | WO | disclosed |
| WO-2022210589-A1 | FUMARIC ACID DIESTER RESIN, FILM AND POLARIZING PLATE | 東ソー株式会社 | 2022-10-06 | — | — | WO | disclosed |
| US-10196373-B2 | Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of STAT protein | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2019-02-05 | — | — | US | disclosed |
| US-20150038708-A1 | SUBSTITUTED 2-HYDROXY-4-(2-(PHENYLSULFONAMIDO)ACETAMIDO)BENZOIC ACID ANALOGS AS INHIBITORS OF STAT PROTEIN | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-02-05 | — | — | US | disclosed |
| US-8846707-B2 | Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of stat protein | UNIVERISTY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) | 2014-09-30 | — | — | US | disclosed |
| WO-2012018868-A1 | SUBSTITUTED 2-HYDROXY-4-(2-(PHENYLSULFONAMIDO)ACETAMIDO)BENZOIC ACID ANALOGS AS INHIBITORS OF STAT PROTEINS | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) | 2012-02-09 | — | — | WO | disclosed |
| US-7923078-B2 | Light-modulating liquid-crystal element | ADEKA CORPORATION (JP) | 2011-04-12 | — | — | US | disclosed |
| US-7923078-B2 | Light-modulating liquid-crystal element | ADEKA CORPORATION (JP) | 2011-04-12 | — | — | US | disclosed |
| US-20090279043-A1 | LIGHT-MODULATING LIQUID-CRYSTAL ELEMENT | ADEKA CORPORATION (JP) | 2009-11-12 | — | — | US | disclosed |
| US-20090279043-A1 | LIGHT-MODULATING LIQUID-CRYSTAL ELEMENT | ADEKA CORPORATION (JP) | 2009-11-12 | — | — | US | disclosed |
| US-20090133746-A1 | Solid-State Electrolyte Composition Containing Liquid Crystal Materials and Dye-Sensitized Solar Cells Using the Same | JIN SUNG HO | 2009-05-28 | — | — | US | disclosed |
| EP-1939268-A1 | LIGHT-MODULATING LIQUID-CRYSTAL ELEMENT | Adeka Corporation (JP) | 2008-07-02 | — | — | EP | disclosed |
| EP-1116770-B1 | NEMATIC LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY USING THE SAME | DAINIPPON INK & CHEMICALS (JP) | 2008-04-02 | — | — | EP | disclosed |
| US-7198827-B1 | Nematic liquid crystal composition and liquid crystal display device using the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2007-04-03 | — | — | US | disclosed |
| US-7198827-B1 | Nematic liquid crystal composition and liquid crystal display device using the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2007-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150038708-A1 | SUBSTITUTED 2-HYDROXY-4-(2-(PHENYLSULFONAMIDO)ACETAMIDO)BENZOIC ACID ANALOGS AS INHIBITORS OF STAT PROTEIN | STAT3, STAT1, STAT4 | CYP2A6 3172/4885TSHR 1268/4885HSD17B10 1696/4885 |
| US-10196373-B2 | Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of STAT protein | STAT3, STAT1, STAT4 | CYP2A6 3172/4885TSHR 1268/4885HSD17B10 1696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.